|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 2018加拿大心境障碍与焦虑障碍治疗协作组/国际双相障碍学会指南:双相障碍的管理显示文摘加拿大心境障碍与焦虑障碍治疗协作组(Canadian Network for Mood and Anxiety Treatments,CANMAT)曾于2005年发布了第1版双相障碍管理指南,并分别于2007、2009和2013年对该指南进行了更新,其中最近的2次更新是与国际双相障碍学会(International Society for Bipolar Disorders,ISBD)合作完成。2018版CANMAT/ISBD双相障碍治疗指南(以下简称指南)反映了自2005年首版指南发表以来本领域取得的重大进展,包括疾病诊断与疾病管理的更新以及药物治疗与心理治疗的近期研究进展。这些前沿进展中综合考虑了循证证据的级别,并基于治疗疗效、临床实践经验、安全性、耐受性和药物导致的转相风险等,对一线、二线及三线治疗方案进行了简明而清晰的推荐。本指南中新增内容涵盖了双相Ⅰ型障碍(BD-Ⅰ)的躁狂发作急性期、抑郁发作急性期和双相障碍维持期的一线及二线治疗推荐等级划分。这种对治疗推荐等级的划分综合考虑了治疗方法对双相障碍不同时相的影响,将进一步帮助临床医生做出基于循证证据的治疗决策。锂盐、喹硫平、双丙戊酸盐、阿塞那平、阿立哌唑、帕利哌酮、利培酮和卡利拉嗪单药或联合使用被推荐为躁狂发作急性期的一线治疗选择。BD-Ⅰ抑郁期的一线治疗选择包括喹硫平、鲁拉西酮、锂盐、拉莫三嗪单药,鲁拉西酮联合锂盐或双丙戊酸盐或拉莫三嗪辅助治疗。尽管急性期治疗有效的药物通常应继续用于BD-Ⅰ的维持期治疗,但也存在一些特殊情况(例如抗抑郁药)。现有数据表明,锂盐、喹硫平、双丙戊酸盐、拉莫三嗪、阿塞那平和阿立哌唑单药或联合治疗应被视为维持治疗的初始或更换治疗方案时的一线选择。除了探讨BD-Ⅰ的相关问题外,本指南中还对双相Ⅱ型障碍(BD-Ⅱ)的临床管理进行了系统回顾并给予治疗推荐,同时针对特殊人群也有相关推荐,如处于各个生殖周期的女性、儿童、青少年和老年人。此外,本指南中还讨论了特定精神疾病及共病(如物质滥用、焦虑障碍和代谢性疾病)的影响。最后,本指南中概述了安全性和药物监测的相关问题。CANMAT/ISBD工作组希望本指南能够成为全球临床医生的实用工具。 | Lakshmi N Yatham Sidney H Kennedy Sagar V Parikh Ayal Sehaffer David J Bond Benicio N Frey Verinder Sharma Benjamin I Goldstein Soham Rej Serge Beaulieu Martin Alda Glenda MaeQueen Roumen V Milev Arun Ravindran Claire O'Donovan Diane Mclntosh Raymond W Lam Gustavo Vazquez Flavio Kapczinski Roger S Melntyre Jan Kozicky Shigenobu Kanba Beny Lafer Trisha Suppes Joseph R Calabrese Eduard Vieta Gin Malhi Robert M Post Michael Berk 胡晨(译) 王刚(译) | 2019 | 中华精神科杂志2019,52,1: | 25 |
| 2 | The treatment of flexion contracture of the knee in myelomeningocele显示文摘 | Abraham E Verinder DG Sharrard WJ | | 0,,04: | 1 |
| 3 | Role of lamotrigine in the management of treatment-esistant bipolar Ⅱ depression: A chart review显示文摘 | Verinder Sharma Mustaq Khan Cynthia Corpse | 2008 | Journal of Affective Disorders2008,1,: | 1 |
| 4 | Retrospective controlled study of inpatient ECT: does it prevent suicide?显示文摘 | Verinder Sharma | 1999 | Journal of Affective Disorders1999,,: | 1 |
| 5 | The evolution of CANMAT Bipolar Disorder Guidelines: past, present, and future显示文摘 | Lakshmi N Yatham Sidney H Kennedy Sagar V Parikh Ayal Schaffer Serge Beaulieu Martin Alda Claire O’Donovan Glenda MacQueen Roger S McIntyre Verinder Sharma Arun Ravindran L Trevor Young Roumen Milev David J Bond Benicio N Frey Benjamin I Goldstein | 2013 | Bipolar Disorders2013,,: | 1 |
| 6 | Paediatric cornea crosslinking current strategies:A review显示文摘Background:In the general population,1 in 2000 people has keratoconus.Indians and other people from Southeast Asia have a higher incidence of keratoconus.Children with keratoconus typically present earlier in life and with a more severe disease.Rubbing the eyes has been identified as a risk factor.Children have a higher incidence and a faster rate of keratoconus progression.Visual rehabilitation in children with keratoconus is challenging.They have a low compliance with contact lens use.Many of these children require penetrating keratoplasty at an early age.Therefore,stopping the progression of keratoconus in children is of paramount importance.Main text:Compared to treatment,keratoconus progression prophylaxis is not only preferable,but also easier.Corneal collagen cross-linking has been shown to be safe and effective in stopping its progression in children.The Dresden protocol,which involves central corneal deepithelization(7-9 mm),saturation of the stroma with riboflavin(0.25%),and 30 min UV-A exposure,has proven to be the most successful.Two significant disadvantages of the typical Dresden regimen are the prolonged operating time and the significant post-operative pain.Accelerated-CXL(9 mW/cm^(2) x 10 min)has been studied to reduce operative time and has been shown to be equally effective in some studies.Compared to accelerated CXL or traditional CXL,epi-off procedures,transepithelial treatment without the need for de-epithelialization and without postoperative discomfort,have been shown to be safer but less effective.Corneal crosslinking should only be performed after treating children with active vernal keratoconjunctivitis.Corneal opacity,chronic corneal edema,sterile infiltrates,and microbial keratitis have been reported after cross-linking of corneal collagen.Conclusions:The'Dresden protocol',also known as the conventional corneal cross-linking approach,should be used to halt the progression of keratoconus in young patients.However,if the procedure needs to be completed more rapidly,accelerated corneal crosslinking may be considered.Transepithelial corneal cross-linking has been proven to be less effective at stabilizing keratoconus,although being more safer. | Pawan Prasher Ashok Sharma Rajan Sharma Vipan K.Vig Verinder S.Nirankari | 2023 | Advances in Ophthalmology Practice and Research2023,3,2: | 0 |
| 7 | Effects of Preheat on the Thermodynamics of the ICF Hot Spot显示文摘 | Jeremy Melvin Hyunkyung Lim Verinder Rana Baolian Cheng James Glimm David H. Sharp Doug C.Wilson | 2015 | Journal of Physical Science and Application2015,5,1: | 0 |